文献速递类风湿关节炎其他结缔组织病

类风湿关节炎相关肺纤维化患者痰液中转化生长因子β升高

Transforming growth factor-beta is increased in sputum from individuals with rheumatoid arthritis-associated pulmonary fibrosis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

该研究纳入37例类风湿关节炎相关肺纤维化(RA-PF)患者和30例无间质性肺病的类风湿关节炎(RA-no-ILD)患者,检测诱导痰和血清TGF-β水平,发现RA-PF组痰液TGF-β显著高于RA-no-ILD组(P < 0.001),且与HRCT纤维化程度及肺功能下降相关,而两组血清TGF-β无差异。

要点

  • RA-PF患者痰液TGF-β较RA-no-ILD患者显著升高(P < 0.001),但血清TGF-β两组无差异。
  • 痰液TGF-β与HRCT纤维化程度(P = 0.005)、用力肺活量(P = 0.006)及一氧化碳弥散量(P = 0.044)相关。
  • 在RA-PF患者中,携带MUC5B ILD风险基因型(GT/TT)者痰液TGF-β更高(P = 0.038)。

核心结论

  • RA-PF患者痰液TGF-β水平显著升高,与肺部疾病严重程度相关,且在携带MUC5B ILD风险多态性的患者中更高,这些发现可能为RA的ILD筛查和RA-ILD的靶向治疗策略提供新思路。

研究设计与样本

  • 研究纳入37例RA-PF患者和30例RA-no-ILD患者,检测诱导痰和血清TGF-β水平,提取DNA确定MUC5B ILD风险等位基因(‘T’),并在痰液采集3个月内完成HRCT和肺功能检查以量化肺部疾病严重程度。

主要发现

  • RA-PF组痰液TGF-β较RA-no-ILD组显著升高(P < 0.001)。
  • 痰液TGF-β与HRCT上更多纤维化(P = 0.005)、更低的用力肺活量(P = 0.006)和一氧化碳弥散量(P = 0.044)相关。
  • 在RA-PF患者中,携带MUC5B ILD风险基因型(GT/TT)者痰液TGF-β更高(P = 0.038)。
  • 两组血清TGF-β水平无差异。

关键数值与推荐

  • 痰液TGF-β在RA-PF组较RA-no-ILD组显著升高(P < 0.001)。
  • 痰液TGF-β与HRCT纤维化程度相关(P = 0.005)。
  • 痰液TGF-β与用力肺活量(P = 0.006)和一氧化碳弥散量(P = 0.044)相关。
  • RA-PF患者中MUC5B ILD风险基因型(GT/TT)者痰液TGF-β更高(P = 0.038)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Interstitial lung disease (ILD) develops in 5-10% of patients with RA and contributes significantly to morbidity and mortality, particularly in those with a fibrotic phenotype. Yet, biomarkers to reliably identify RA patients with underlying pulmonary fibrosis are inadequate. Herein, we used sputum to identify lung-based biomarkers that distinguish RA patients with underlying pulmonary fibrosis and may better inform underlying pathogenesis in RA-ILD. METHODS: We included 37 RA patients with pulmonary fibrosis (RA-PF) and 30 RA patients without ILD (RA-no-ILD). Induced sputum and serum were tested for TGF-β levels by immunoassay. DNA was extracted to determine presence of the MUC5B ILD-risk allele ('T'). High-resolution CT (HRCT) and pulmonary function tests (PFTs) were completed within 3 months of sputum collection and quantified to determine lung disease severity. RESULTS: Sputum TGF-β was significantly elevated in individuals with RA-PF compared with RA-no-ILD (P < 0.001) and correlated with more fibrosis on HRCT (P = 0.005) and lower forced vital capacity (P = 0.006) and diffusion capacity of carbon monoxide (P = 0.044) on PFTs. Within RA-PF patients, sputum TGF-β was higher in those with the MUC5B ILD-risk genotype (GT/TT) (P = 0.038). There were no differences in serum levels of TGF-β between groups. CONCLUSION: We demonstrate that sputum levels of TGF-β are significantly elevated in individuals with RA-PF, correlate with lung disease severity, and are elevated in those with the MUC5B ILD-risk polymorphism. These findings could identify novel approaches to ILD screening in RA and potential targeted therapeutic strategies for RA-ILD.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wilson TM, Bolt M, Stahly A, et al. Transforming growth factor-beta is increased in sputum from individuals with rheumatoid arthritis-associated pulmonary fibrosis. Rheumatology (Oxford). 2025. PMID: 39693122. doi:10.1093/rheumatology/keae697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。